Skip to content

EV / sales at other companies

Universal Health Services logo
Universal Health ServicesUHS
0.9×-0.2×
HCA Healthcare logo
HCA HealthcareHCA
+0.2×
ARD
Ardent Health PartnersARDT
0.3×-0.2×
Nutex Health Inc. logo
Nutex Health Inc.NUTX
0.9×+0.1×
Surgery Partners, Inc. logo
Surgery Partners, Inc.SGRY
1.9×-0.5×
National Healthcare logo
National HealthcareNHC
1.6×+0.5×

Other financials

Income statement

See full
Revenue$3.0B-6.1%
Gross profit$2.5B-5.5%
Operating income$281.0M-1.1%
Net income-$58.0M-346%
EPS (diluted)-$0.43-330%

Balance sheet

See full
Cash & equivalents$712.0M+65.2%
Total debt$11.0B-10.0%
Total equity-$1.5B+24.4%
Total assets$13.2B-5.1%

Cash flow

See full
Operating cash flow-$297.0M-348%
CapEx$76.0M-10.6%
Free cash flow-$373.0M-1,166%

Valuation

See full
Market cap$450.93M-2.9%
Enterprise value$10.7B-12.4%
P/E
P/S0.0×

Profitability

See full
Gross margin85.2%+0.6pp
Operating margin12.1%+7.4pp
Net margin3.8%+2.5pp
FCF margin-1.6%-2.8pp

Returns & leverage

See full
Return on equity-43.9%
Debt / equity11.5×
Current ratio1.5×0.0×

Where this comes from

Calculated from Community Health Systems’s reported figures.

Based on the most recent quarter.

The official record: Community Health Systems’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Community Health Systems's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Community Health Systems's EV / sales?
Community Health Systems (CYH) reported EV / sales of 0.9× in Q1 2026.
How has Community Health Systems's EV / sales changed year-over-year?
Community Health Systems's EV / sales decreased by 9.5% year-over-year, from 1× to 0.9×.
What is the long-term trend for Community Health Systems's EV / sales?
Over 5 years (2020 to 2025), Community Health Systems's EV / sales has grown at a -2.5% compound annual growth rate (CAGR), from 1× to 0.9×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.